Structural Insights into Notum Covalent Inhibition.
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
12 08 2021
12 08 2021
Historique:
pubmed:
23
7
2021
medline:
30
1
2022
entrez:
22
7
2021
Statut:
ppublish
Résumé
The carboxylesterase Notum hydrolyzes a palmitoleate moiety from Wingless/Integrated(Wnt) ligands and deactivates Wnt signaling. Notum inhibitors can restore Wnt signaling which may be of therapeutic benefit for pathologies such as osteoporosis and Alzheimer's disease. We report the identification of a novel class of covalent Notum inhibitors, 4-(indolin-1-yl)-4-oxobutanoate esters. High-resolution crystal structures of the Notum inhibitor complexes reveal a common covalent adduct formed between the nucleophile serine-232 and hydrolyzed butyric esters. The covalent interaction in solution was confirmed by mass spectrometry analysis. Inhibitory potencies vary depending on the warheads used. Mechanistically, the resulting acyl-enzyme intermediate carbonyl atom is positioned at an unfavorable angle for the approach of the active site water, which, combined with strong hydrophobic interactions with the enzyme pocket residues, hinders the intermediate from being further processed and results in covalent inhibition. These insights into Notum catalytic inhibition may guide development of more potent Notum inhibitors.
Identifiants
pubmed: 34292747
doi: 10.1021/acs.jmedchem.1c00701
pmc: PMC8365597
doi:
Substances chimiques
Butyrates
0
Enzyme Inhibitors
0
Esters
0
Indoles
0
indoline
6DPT9AB2NK
Esterases
EC 3.1.-
Notum protein, human
EC 3.1.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11354-11363Subventions
Organisme : Wellcome Trust
ID : 106169/ZZ14/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C375/A17721
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203141/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001002
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001002
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001002
Pays : United Kingdom
Références
Science. 2012 Jul 6;337(6090):59-64
pubmed: 22653731
J Med Chem. 2018 Jun 14;61(11):4938-4945
pubmed: 29741894
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
pubmed: 15299926
Dev Cell. 2015 Dec 7;35(5):632-645
pubmed: 26651295
Vet Pathol. 2016 Jul;53(4):853-62
pubmed: 26926082
Cell. 2004 Mar 19;116(6):883-95
pubmed: 15035989
J Biomol Screen. 2013 Oct;18(9):1084-91
pubmed: 23749765
J Pineal Res. 2020 Mar;68(2):e12630
pubmed: 31876313
Dev Cell. 2015 Mar 23;32(6):719-30
pubmed: 25771893
J Med Chem. 2020 Nov 12;63(21):12942-12956
pubmed: 33124429
Structure. 2007 Mar;15(3):267-73
pubmed: 17355862
Dev Biol. 2018 Apr 1;436(1):14-27
pubmed: 29428562
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126751
pubmed: 31862412
ACS Med Chem Lett. 2018 May 26;9(6):563-568
pubmed: 29937983
Biochemistry. 2014 Sep 16;53(36):5820-9
pubmed: 25101647
Nat Commun. 2020 Oct 9;11(1):5114
pubmed: 33037205
Science. 2011 May 13;332(6031):852-5
pubmed: 21566195
Medchemcomm. 2019 Apr 29;10(8):1361-1369
pubmed: 31534655
J Med Chem. 2020 Sep 10;63(17):9464-9483
pubmed: 32787107
Bone Res. 2019 Jan 8;7:2
pubmed: 30622831
Nat Commun. 2014 Jul 14;5:4321
pubmed: 25027712
Drug Discov Today. 2010 Aug;15(15-16):648-55
pubmed: 20570751
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Commun Biol. 2020 Oct 8;3(1):555
pubmed: 33033363
Genes Dev. 1996 Dec 15;10(24):3116-28
pubmed: 8985181
Front Cell Dev Biol. 2020 Sep 16;8:860
pubmed: 33042988
Biochemistry. 2005 Apr 19;44(15):5561-71
pubmed: 15823014
Bioorg Med Chem. 2021 Jan 1;29:115865
pubmed: 33285410
ChemMedChem. 2019 May 6;14(9):889-906
pubmed: 30816012
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13371-3
pubmed: 12374850
J Neurosci. 2013 Jan 30;33(5):2177-87
pubmed: 23365253
Acta Crystallogr D Biol Crystallogr. 2005 Jun;61(Pt 6):651-7
pubmed: 15930615
Nature. 2019 Jul;571(7765):398-402
pubmed: 31292548
Cell Rep. 2020 Jun 23;31(12):107805
pubmed: 32579931
Development. 2017 Oct 1;144(19):3499-3510
pubmed: 28860114
Nature. 2015 Mar 12;519(7542):187-192
pubmed: 25731175
PLoS One. 2012;7(4):e36219
pubmed: 22558390
Nat Methods. 2006 Sep;3(9):729-35
pubmed: 16929319
Brain Sci. 2020 Nov 24;10(12):
pubmed: 33255414
Cell Metab. 2018 May 01;27(5):1138-1155.e6
pubmed: 29719227
Nature. 2021 Jun;594(7863):430-435
pubmed: 34079124
J Med Chem. 2017 Jul 27;60(14):5943-5954
pubmed: 28388050
Future Med Chem. 2021 Jun;13(11):1001-1015
pubmed: 33882714
Mol Metab. 2021 Jul;49:101201
pubmed: 33647468
J Cell Biochem. 2015 Oct;116(10):2139-45
pubmed: 25833316
PLoS One. 2016 Mar 14;11(3):e0150997
pubmed: 26974334
Nature. 2016 Jul 7;535(7610):169-172
pubmed: 27362232
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13419-24
pubmed: 12370423
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
J Med Chem. 2021 Apr 22;64(8):4289-4311
pubmed: 33783220
ChemMedChem. 2008 Mar;3(3):435-44
pubmed: 18064617
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1260-73
pubmed: 23793152
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Drug Discov Today. 2015 Sep;20(9):1061-73
pubmed: 26002380